R. Matthew

A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor ('SPROG' trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN.

S. Chan, D. Adamson, K. Benstead, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

OP-JNCI190078 1..12

Derick R. Peterson, Sydes, H. Ostrer, 2019 .

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5,456 breast and prostate cancer patients

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

ATM rs1801516 SNP and toxicity after radiotherapy

Sydes, H. Ostrer, J. Chang-Claude, 2017 .

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.

Adam P Dicker, Menggang Yu, Hussam Al-Deen Ashab, 2016, The Lancet. Oncology.